Figure 1.
Dose–response curves of prostate cell lines upon hydralazine (A), enzalutamide (B), and bicalutamide (C) treatment. EC50 values after 72 h of treatment are indicated in each graph.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.